LexDanaLexDanabeta
Inventor

Peter Wipf

Inventor
Pittsburgh, PA, US

Overview

69→
Patents
1997–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 69 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds24%
C07KPeptides6%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07BGeneral methods of organic chemistry3%
Y02ATechnologies for adaptation to climate change2%
A61QSpecific use of cosmetics or similar toiletry preparations2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
11,111,2536-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity202111,090,389Mitochondrially targeted PARP inhibitor, and uses thereof202110,980,806Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer202110,968,196Substituted b-lapachones for treating cancer202110,933,077TLR4 inhibitors for the treatment of human infectious and inflammatory disorders202110,906,876Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors202110,894,782Modulators of P97 AAA ATPase activity202110,882,834Compounds for treating prostate cancer202110,751,273Compounds for the treatment of pathologies associated with aging and degenerative disorders202010,752,629Calcium channel agonists202010,668,092Compositions and methods for treatment of inflammatory disorders202010,633,370Phenyl indole allosteric inhibitors of p97 ATPase202010,618,9146-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity202010,544,110Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer202010,526,368Targeted nitroxide agents202010,526,280(2-amino-4-(arylamino)phenyl carbamates202010,478,437Combination therapy to enhance the anticancer efficacy of platinum drugs201910,450,289Substituted b-lapachones for treating cancer201910,308,663Inhibitors of PTP4A3 for the treatment of cancer201910,300,083TLR4 inhibitors for the treatment of human infectious and inflammatory disorders201910,251,860Compounds for bone healing201910,172,795Formulations and carrier systems including compound interactive domains201910,174,031Calcium channel agonists201910,004,730Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer20189,981,974Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer20189,938,250Antifibrotic effects of oxetanyl sulfoxides20189,890,192'Targeted nitroxide agents'20189,840,515'Protein kinase D inhibitors'20179,796,681'Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors'20179,796,714'Calcium channel agonists'20179,732,105'Targeted nitroxide agents'20179,708,276'Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer'20179,676,738'Antifibrotic effects of oxetanyl sulfoxides'20179,675,446'Prosthetic implant for medialization thyroplasty'20179,546,144'Bifunctional compounds'20179,532,999'TLR4 inhibitors for the treatment of human infectious and inflammatory disorders'20179,402,839'Selective targeting agents for mitochondria'20169,220,711'Compounds for the treatment of pathologies associated with aging and degenerative disorders'20159,216,976'Targeted nitroxide agents'20159,217,000'Targeted nitroxide agents'20159,200,035'Bifunctional compounds'20159,169,182'Chrysophaentin analogs that inhibit FtsZ protein'20159,072,760'TLR4 inhibitors for the treatment of human infectious and inflammatory disorders'20159,006,186'Selective targeting agents for mitochondria'20158,937,086'Compounds for the treatment of pathologies associated with aging and degenerative disorders'20158,822,541'Use of targeted nitroxide agents in mitigating or treating radiation injury'20148,748,369'Use of targeted nitroxide agents in bone healing'20148,609,850'Targeted nitroxide agents'20138,487,079'Use of mitochondria-targeted electron scavengers as anti-inflammatory agents'20138,288,551'Targeted nitroxide agents'20128,124,651'Palmarumycin based inhibitors of thioredoxin and methods of using same'20127,858,657'Wortmannin analogs and methods of using same in combination with chemotherapeutic agents'20107,776,908'Wortmannin analogs and methods of using same'20107,718,603'Selective targeting agents for mitochondria'20107,528,174'Selective targeting agents for mitochondria'20097,446,124'Wortmannin analogs and methods of using same in combination with chemotherapeutic agents'20087,335,679'Wortmannin analogs and methods of using same'20087,166,725'Benzo[d]isoxazol-3-ol DAAO inhibitors'20076,803,475'Fluorous tagging compounds and methods of use thereof'20046,673,539'Fluorous tagging compounds and methods of use thereof'20046,673,937'Syntheses and methods of use of new antimitotic agents'20046,392,055'Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A'20026,156,896'Fluorous reaction and separation systems'20006,040,323'Phosphatase inhibitors and methods of use thereof'20005,952,294'Peptidyl prodrugs and methods of making and using the same'19995,925,660'Phosphatase inhibitors and methods of use thereof'19995,859,247'Fluorous reaction and separation systems'19995,856,506'Phosphatase inhibitors and methods of use thereof'19995,700,821'Phosphatase inhibitors and methods of use thereof'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2015Patents assigned to UNIV PITTSBURGH (22)· patent assignee history
1997–2021Based in Pittsburgh, PA, US· patent location history
2008–2012Patents assigned to UNIV ARIZONA (5)· patent assignee history
2012–2019Patents assigned to WIPF PETER (13)· patent assignee history
2012Based in Pittsburg, PA, US· patent location history
2014–2015Patents assigned to UNIV PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (7)· patent assignee history
2016–2021Patents assigned to UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (36)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION362016–2021
UNIV PITTSBURGH221997–2015
WIPF PETERself132012–2019
UNIV PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION72014–2015
UNIV ARIZONA52008–2012
Locations
LocationPatentsSpan
Pittsburgh, Pennsylvania, US681997–2021
Pittsburg, Pennsylvania, US12012